Cystic Fibrosis Gastric Organoids
Source Berkers et al., 2019 · University Medical Center Utrecht, Department of Pediatric Pulmonology · 10.1016/j.celrep.2019.01.068
Abstract
This protocol describes the culture of rectal organoids derived from cystic fibrosis patients and the functional assessment of CFTR modulator drug responses using forskolin-induced swelling (FIS) measurements. The assay quantifies individual drug efficacy in vitro and correlates with clinical outcomes (ppFEV1 and sweat chloride concentration), enabling personalized treatment selection for CF patients.
Protocol overview
19 steps across 4 phases
- a Obtain rectal tissue biopsy
- b Establish organoid culture from rectal tissue
- c Maintain organoid cultures in growth medium
- a Prepare test drugs and control
- b Prepare forskolin working solutions
- c Prepare organoid wells for imaging
- d Prepare fluorescent labeling solution
- a Label organoids with Calcein, AM
- b Establish baseline organoid area (t=0 min)
- c Add DMSO control or drug + forskolin
- d Acquire real-time confocal images for 60 minutes
- e Measure organoid area at end-point (t=60 min)
- f Quantify organoid swelling response
- a Calculate drug response for each sample
- b Collect in vivo clinical endpoint data
- c Perform Pearson correlation analysis
- d Generate receiver operating characteristic (ROC) curves
- e Calculate predictive values
- f Perform leave-one-out cross-validation
Full SOP
Full SOPs need an account and a plan
Create an account, then get free Academic access (for verified academics) or choose a plan. Plans include step-by-step procedures, reagent concentrations, QC checklists and batch record templates.
Create an accountAlready registered? Log in
Attribution
This SOP was written by Organthis based on the published method in Berkers et al., 2019. Once the originating laboratory has confirmed it, the SOP is marked Verified.
Something wrong with this entry? Report an issue with this protocol